Skip to main content

Table 3 Descriptive characteristics

From: Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency

  Group I before treatment average results (n =43) Group I after treatment average results (n =43) Group II before treatment average results (n =42) Group II after treatment average results (n =42)
BMI 35.65 29.68 36.60 31.88
F.test 3.85 12.06 3.8 6.64
HbA1c 8.26 7.46 8.43 7.93
Leptin 21.71 11.64 23.19 13.93
Chol 211.17 194.64 207.28 198.02
TG 185.6 178.31 182.21 180.23
HDL 55.5 71.11 54 68.44
LDL 102.95 95.62 99.58 96.3
  1. Data are expressed as mean ± SD. BMI: body mass index; Chol: cholesterol; F.test: free testosterone; HbA1c: glycosylated hemoglobin; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; TC: total cholesterol; TG: triglyceride.